Skip to main content
PMC home page
Gut logoLink to Gut
. 1990 Jul;31(7):825–830. doi: 10.1136/gut.31.7.825

Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study.

A L Blum 1, H Bethge 1, J C Bode 1, W Domschke 1, G Feurle 1, K Hackenberg 1, B Hammer 1, W Hüttemann 1, M Jung 1, G Kachel 1, et al.
PMCID: PMC1378545  PMID: 2196208

Abstract

A randomised controlled multicentre trial was performed in 160 patients with gastric ulcer, proved by endoscopy and biopsy, to compare ulcer healing with sucralfate and ranitidine (double blind double dummy design) and to assess the effect of maintenance treatment with sucralfate on ulcer recurrence (double blind placebo controlled design). The healing rates were similar with 4 g sucralfate suspension per day and 300 mg ranitidine per day (82% and 88% after 12 weeks, respectively). Of the 109 patients with healed ulcers, 92 were entered into the maintenance trial and treated with sucralfate tablets (2 g per day) or placebo tablets. Maintenance treatment with sucralfate delayed symptoms of gastric ulcer recurrence. Lifetable analysis showed significant differences between sucralfate and placebo, both after six months (p = 0.018) and after 12 months (p = 0.044). The rates of symptom recurrences were 13% and 34% after six months and 34% and 55% after 12 months for sucralfate and placebo, respectively. The rate of asymptomatic recurrences after 12 months was similar in the two groups (9% and 10%, respectively). The recurrence rate was higher in patients who had never taken non-steroidal anti-inflammatory drugs than in those who had but had stopped on admission to the study. It was also higher in patients with recurrent ulcer and in those with scarring deformation and narrowing of the pylorus. Maintenance treatment with sucralfate slowed the appearance of symptom recurrences of gastric ulcer.

Full text

PDF
830

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alp M. H., Hislop I. G., Grant A. K. The influence of site on the natural history of gastric ulceration. Surg Gynecol Obstet. 1972 Mar;134(3):470–472. [PubMed] [Google Scholar]
  2. Alstead E. M., Ryan F. P., Holdsworth C. D., Ashton M. G., Moore M. Ranitidine in the prevention of gastric and duodenal ulcer relapse. Gut. 1983 May;24(5):418–420. doi: 10.1136/gut.24.5.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barr G. D., Kang J. Y., Canalese J., Piper D. W. A two-year prospective controlled study of maintenance cimetidine and gastric ulcer. Gastroenterology. 1983 Jul;85(1):100–104. [PubMed] [Google Scholar]
  4. Blum A. L., Bode J. C., Domschke W., Feurle G., Hackenberg K., Hammer B., Hüttemann W., Kachel G., Kaess H., Manegold B. C. Therapie des Ulcus ventriculi mit Sucralfat und Ranitidin. Eine multizentrische Doppelblindstudie. Dtsch Med Wochenschr. 1986 Dec 12;111(50):1910–1915. doi: 10.1055/s-2008-1068734. [DOI] [PubMed] [Google Scholar]
  5. Bodemar G., Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet. 1978 Feb 25;1(8061):403–407. doi: 10.1016/s0140-6736(78)91200-x. [DOI] [PubMed] [Google Scholar]
  6. CUTLER S. J., EDERER F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958 Dec;8(6):699–712. doi: 10.1016/0021-9681(58)90126-7. [DOI] [PubMed] [Google Scholar]
  7. Classen M., Bethge H., Brunner G., Dirr B., Frotz H., Gabor M., Gail H., Grabner R., Hagenmüller F., Heinkel K. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study. Scand J Gastroenterol Suppl. 1983;83:61–68. [PubMed] [Google Scholar]
  8. Da Silva E. P., Zaterka S. Long-term treatment of gastric ulcer with cimetidine. Clin Ther. 1981;4(1):24–31. [PubMed] [Google Scholar]
  9. Danielsson A., Ek B., Steen L. Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence. Eur J Clin Pharmacol. 1981;19(5):335–341. doi: 10.1007/BF00544583. [DOI] [PubMed] [Google Scholar]
  10. Daschner F., Reuschenbach K., Pfisterer J., Kappstein I., Vogel W., Krieg N., Just H. Der Einfluss von Stressulcusprophylaxe auf die Häufigkeit einer Beatmungspneumonie. Anaesthesist. 1987 Jan;36(1):9–18. [PubMed] [Google Scholar]
  11. Dawson J., Jain S., Cockel R. Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence. Scand J Gastroenterol. 1984 Jul;19(5):665–668. [PubMed] [Google Scholar]
  12. Dobrilla G., Vallaperta P., Amplatz S. Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials. Gut. 1988 Feb;29(2):181–187. doi: 10.1136/gut.29.2.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dragstedt L. R., Woodward E. R. Gastric stasis, a cause of gastric ulcer. Scand J Gastroenterol Suppl. 1970;6:243–252. [PubMed] [Google Scholar]
  14. Driks M. R., Craven D. E., Celli B. R., Manning M., Burke R. A., Garvin G. M., Kunches L. M., Farber H. W., Wedel S. A., McCabe W. R. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med. 1987 Nov 26;317(22):1376–1382. doi: 10.1056/NEJM198711263172204. [DOI] [PubMed] [Google Scholar]
  15. Gibiński K., Nowak A., Gabryelewicz A., Szałaj W., Hasik J., Klincewicz H., Butruk E., Kosecki P., Pokora J., Radwan P. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study. Hepatogastroenterology. 1984 Aug;31(4):180–182. [PubMed] [Google Scholar]
  16. Hallerbäck B., Solhaug J. H., Carling L., Glise H., Hallgren T., Kagevi I., Svedberg L. E., Wählby L. Recurrent ulcer after treatment with cimetidine or sucralfate. Scand J Gastroenterol. 1987 Sep;22(7):791–797. doi: 10.3109/00365528708991916. [DOI] [PubMed] [Google Scholar]
  17. Hanscom D. H., Buchman E. The Veterans Administration Cooperative Study on Gastric Ulcer. 4. The follow-up period. Gastroenterology. 1971 Oct;61(4 Suppl):585–591. [PubMed] [Google Scholar]
  18. Hentschel E., Schütze K., Weiss W., Rüdiger E., Judmair G., Reichel W., Kerstan E., Horton J. Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study. Gut. 1983 Sep;24(9):853–856. doi: 10.1136/gut.24.9.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jean F., Bonnefond A., Gislon J., Kloeti G., Libeskind M., Petite J. P., Rautureau J., Roberti A., Zeitoun P. Traitement d'entretien de la maladie ulcéreuse. Etude multicentrique comparative du sucralfate, de la cimétidine et d'un placebo. Rev Med Interne. 1985 Jun;6(3):321–326. doi: 10.1016/s0248-8663(85)80125-9. [DOI] [PubMed] [Google Scholar]
  20. Jensen K. B., Møllmann K. M., Rahbek I., Madsen J. R., Rune S. J., Wulff H. R. Prophylactic effect of cimetidine in gastric ulcer patients. Scand J Gastroenterol. 1979;14(2):175–176. doi: 10.3109/00365527909179865. [DOI] [PubMed] [Google Scholar]
  21. Jorde R., Bostad L., Burhol P. G. Asymptomatic gastric ulcer: a follow-up study in patients with previous gastric ulcer disease. Lancet. 1986 Jan 18;1(8473):119–121. doi: 10.1016/s0140-6736(86)92260-9. [DOI] [PubMed] [Google Scholar]
  22. Jorde R., Burhol P. G., Hansen T. Ranitidine 150 mg at night in the prevention of gastric ulcer relapse. Gut. 1987 Apr;28(4):460–463. doi: 10.1136/gut.28.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lee F. I., Samloff I. M., Hardman M. Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet. 1985 Jun 8;1(8441):1299–1302. doi: 10.1016/s0140-6736(85)92793-x. [DOI] [PubMed] [Google Scholar]
  24. Libeskind M. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine. Scand J Gastroenterol Suppl. 1983;83:69–70. [PubMed] [Google Scholar]
  25. Liebermann-Meffert D., Allgöwer M. The morphology of the antrum and pylorus in gastric ulcer disease. Prog Surg. 1977;15:109–139. doi: 10.1159/000399582. [DOI] [PubMed] [Google Scholar]
  26. Liedberg G., Davies H. J., Enskog L., Eriksson S., Frederiksen B., Graffner H., Hradsky M., Oscarson J., Rydberg B., Simert G. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease. Scand J Gastroenterol. 1985 Oct;20(8):941–944. doi: 10.3109/00365528509088852. [DOI] [PubMed] [Google Scholar]
  27. Machell R. J., Ciclitira P. J., Farthing M. J., Dick A. P., Hunter J. O. Cimetidine in the prevention of gastric ulcer relapse. Postgrad Med J. 1979 Jun;55(644):393–395. doi: 10.1136/pgmj.55.644.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Manniche C., Malchow-Møller A., Andersen J. R., Pedersen C., Hansen T. M., Jess P., Helleberg L., Rasmussen S. N., Tage-Jensen U., Nielsen S. E. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut. 1987 Feb;28(2):226–229. doi: 10.1136/gut.28.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Marks I. N., Girdwood A. H., Wright J. P., Newton K. A., Gilinsky N. H., Kalvaria I., Burns D. G., O'Keefe S. J., Tobias R., Lucke W. Nocturnal dosage regimen of sucralfate in maintenance treatment of gastric ulcer. Am J Med. 1987 Sep 28;83(3B):95–98. doi: 10.1016/0002-9343(87)90836-9. [DOI] [PubMed] [Google Scholar]
  30. Marks I. N., Wright J. P., Girdwood A. H., Gilinsky N. H., Lucke W. Maintenance therapy with sucralfate reduces rate of gastric ulcer recurrence. Am J Med. 1985 Aug 30;79(2C):32–35. doi: 10.1016/0002-9343(85)90569-8. [DOI] [PubMed] [Google Scholar]
  31. Marks I. N., Wright J. P., Lucke W., Girdwood A. H. Relapse rates after initial ulcer healing with sucralfate and cimetidine. Scand J Gastroenterol. 1982 Apr;17(3):429–432. doi: 10.3109/00365528209182081. [DOI] [PubMed] [Google Scholar]
  32. Miyake T., Ariyoshi J., Suzaki T., Oishi M., Sakai M., Ueda S. Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers. Dig Dis Sci. 1980 Jan;25(1):1–7. doi: 10.1007/BF01312725. [DOI] [PubMed] [Google Scholar]
  33. Morgan A. G., McAdam W. A., Pacsoo C., Darnborough A. Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut. 1982 Jun;23(6):545–551. doi: 10.1136/gut.23.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Morgan A. G., McAdam W. A., Pacsoo C., Walker B. E., Simmons A. V. Cimetidine: an advance in gastric ulcer treatment? Br Med J. 1978 Nov 11;2(6148):1323–1326. doi: 10.1136/bmj.2.6148.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Morgan A. G., Pacsoo C., McAdam W. A. Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. Gut. 1985 Jun;26(6):599–602. doi: 10.1136/gut.26.6.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pace F., Bröker H. J., Caspary W., Domschke W., Feurle G., Fimmel C. J., Hackenberg K., Hammer B., Holtermüller K. H., Hotz J. Therapie des Ulcus ventriculi mit niedrig dosiertem Antacidumgel und Cimetidin. Eine multizentrische Doppelblindstudie. Dtsch Med Wochenschr. 1985 Feb 22;110(8):283–287. doi: 10.1055/s-2008-1068813. [DOI] [PubMed] [Google Scholar]
  37. Piper D. W., Greig M., Coupland G. A., Hobbin E., Shinners J. Factors relevant to the prognosis of chronic gastric ulcer. Gut. 1975 Sep;16(9):714–718. doi: 10.1136/gut.16.9.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Piper D. W., Pym B. M., Toy S., Gellatly R., Byth K., Seville P. The effect of maintenance cimetidine therapy on the medical, social and economic aspects of patients with chronic gastric ulcers. A placebo-controlled prospective study. Med J Aust. 1986 Oct 20;145(8):400–403. [PubMed] [Google Scholar]
  39. Piper D. W., Shinners J., Greig M., Thomas J., Waller S. L. Effect of ulcer healing on the prognosis of chronic gastric uler. Four-year follow-up. Gut. 1978 May;19(5):419–424. doi: 10.1136/gut.19.5.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rohner H. G. Long term cimetidine therapy for the prevention of recurring peptic ulcer: a multicenter study. Z Gastroenterol. 1985 Aug;23(8):403–411. [PubMed] [Google Scholar]
  41. Sipponen P., Kekki M., Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer. 1984 Apr;49(4):521–530. doi: 10.1038/bjc.1984.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Solhaug J. H., Carling L., Glise H., Hallerbäck B., Hallgren T., Kagevi I., Svedberg L. E., Wählby L. Ulcer recurrences following initial ulcer healing with sucralfate or cimetidine. Scand J Gastroenterol Suppl. 1987;127:77–80. [PubMed] [Google Scholar]
  43. Ström M., Gotthard R., Bodemar G., Walan A. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers. Scand J Gastroenterol. 1981;16(5):593–602. doi: 10.3109/00365528109182017. [DOI] [PubMed] [Google Scholar]
  44. Sutton D. R. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. Gut. 1982 Jul;23(7):621–624. doi: 10.1136/gut.23.7.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Takemoto T., Kimura K., Okita K., Tsuneoka K., Ohshiba S., Namiki M., Fukuchi S., Miyake T., Fukutomi H., Okazaki Y. Efficacy of sucralfate in the prevention of recurrence of peptic ulcer--double blind multicenter study with cimetidine. Scand J Gastroenterol Suppl. 1987;140:49–60. [PubMed] [Google Scholar]
  46. Tatsuta M., Iishi H., Okuda S. Effects of cigarette smoking on the location, healing and recurrence of gastric ulcers. Hepatogastroenterology. 1987 Oct;34(5):223–228. [PubMed] [Google Scholar]
  47. Thomas J. M., Misiewicz J. J., Cook A. R., Hill M. J., Smith P. L., Walters C. L., Forster J. K., Martin L. E., Woodings D. F. Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut. 1987 Jun;28(6):726–738. doi: 10.1136/gut.28.6.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Thomas J., Greig M., McIntosh J., Hunt J., McNeil D., Piper D. W. The location of chronic gastric ulcer: a study of the relevance of ulcer size, age, sex, alcohol, analgesic intake and smoking. Digestion. 1980;20(2):79–84. doi: 10.1159/000198422. [DOI] [PubMed] [Google Scholar]
  49. Walan A., Bianchi-Porro G., Hentschel E., Bardhan K. D., Delattre M. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol. 1987 May;22(4):397–405. doi: 10.3109/00365528708991481. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES